About BioChromix



   Home


   About BioChromix
   Products
   Development
   Technology
   News and Press
   Publications
   Management

 

 

 

 

 

 

 

 

 

 

 

 

 

 

History, present and future of BioChromix

BioChromix was founded on the 10th of December 2003, on the Nobel day. The company's base and platform lies in the research done at the University of Linköping, especially the use of luminescent polyelectrolytes in relation to neurodegenerative proteopathy diseases. BioChromix has since inception working closely with companies, research groups at the university and at other universities, in order to develop BioChromix technology.

The primary focus is on the Company's reagents to detect, monitor and treatment of Alzheimer's disease. To achieve our goals as efficient as possible BioChromix will work closely with customers, CROs, as well as performing research and development in-house.

The future lies bright and open for BioChromix, with applications of the technology in many interesting, expanding areas. Development and research will continue and bring forward new knowledge, applications and products.

BioChromix is a competent, creative and dynamic state-of-the art art life science company, with exciting products and development, based on the Company's unique LCP molecules, that enhances and simplifies the analysis of biological systems.
Innovation is in our blood
BioChromix AB is a dynamic, innovative, highly enthusiastic company that is motivated by its search and development which seek to expand the realm of protein misfolding and aggregation. Development has resulted in a unique development line of LCP molecules which are used for in vitro assays or even inside the living (in vivo) organism as molecular imaging agents and targeted diagnostics. It is BioChromix primary strategic plan to focus strongly on the further development of an exciting pipeline of product candidates that are designed to address vital unmet medical needs within the filed of protein misfolding and aggregation, specifically in vitro assays and in vivo live imaging for Alzheimer's Disease.

We are always open to meet new potential partners or customer and to hear about suggestions of new collaborative projects using our unique probes. BioChromix has since start up collaborated with several companies in such way.
    About Us | Legal Notice | Contact Us | ©2009 BioChromix